4//SEC Filing
Spiess Bernhard E. 4
Accession 0001447362-21-000213
CIK 0001447362other
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 5:26 PM ET
Size
16.3 KB
Accession
0001447362-21-000213
Insider Transaction Report
Form 4
Spiess Bernhard E.
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2021-09-02$2.39/sh+6,412$15,325→ 28,963 total - Sale
Common Stock
2021-09-02$76.14/sh−5,889$448,388→ 15,036 total - Sale
Common Stock
2021-09-02$75.24/sh−8,038$604,779→ 20,925 total - Exercise/Conversion
Common Stock
2021-09-02$1.92/sh+8,989$17,259→ 22,551 total - Sale
Common Stock
2021-09-02$77.29/sh−1,474$113,925→ 13,562 total - Exercise/Conversion
Stock option (right to buy)
2021-09-02−8,989→ 5,889 totalExercise: $1.92Exp: 2026-05-23→ Common Stock (8,989 underlying) - Exercise/Conversion
Stock option (right to buy)
2021-09-02−6,412→ 2,304 totalExercise: $2.39Exp: 2028-05-09→ Common Stock (6,412 underlying)
Footnotes (6)
- [F1]These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on August 19, 2021.
- [F2]This transaction was executed in multiple trades at prices ranging from $74.59 to $75.58, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $75.60 to $76.45, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $76.70 to $77.63, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]25% of the 169,592 shares originally subject to the option vested on May 2, 2017, and the remaining shares vested in 36 equal monthly installments thereafter.
- [F6]25% of the 12,305 shares originally subject to the option vested on May 10, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.
Documents
Issuer
CASTLE BIOSCIENCES INC
CIK 0001447362
Entity typeother
Related Parties
1- filerCIK 0001782994
Filing Metadata
- Form type
- 4
- Filed
- Sep 6, 8:00 PM ET
- Accepted
- Sep 7, 5:26 PM ET
- Size
- 16.3 KB